News & Events

Durable response to sotorasib-based combination therapy in advanced lung adenocarcinoma harboring KRAS G12C and STK11 mutations: a case report

Durable response to sotorasib-based combination therapy in advanced lung adenocarcinoma harboring KRAS G12C and STK11 mutations: a case report

Investigators from Tianjin Medical University Target Personalized Medicine (A Ct Imaging-based Deep Learning Model for Predicting Egfr and Kras Mutations In Non-small Cell Lung Cancer:...

Investigators from Tianjin Medical University Target Personalized Medicine (A Ct Imaging-based Deep Learning Model for Predicting Egfr and Kras Mutations In Non-small Cell Lung Cancer:...

Selinexor and Docetaxel Indicate Promise in KRAS-Mutant NSCLC

Selinexor and Docetaxel Indicate Promise in KRAS-Mutant NSCLC

Cetuximab Boosts KRAS G12C Inhibitors in Lung Cancer

Cetuximab Boosts KRAS G12C Inhibitors in Lung Cancer

UK's NICE Does Not Recommend Lumakras for KRAS G12C-Mutant NSCLC, Asks for More Data

UK's NICE Does Not Recommend Lumakras for KRAS G12C-Mutant NSCLC, Asks for More Data

和誉医药口服小分子KRAS G12D抑制剂ABSK141完成首例患者给药

和誉医药口服小分子KRAS G12D抑制剂ABSK141完成首例患者给药

Findings from University of Malakand Provide New Insights into Computational Biophysics and Chemistry (Transfiguring Novel Marine Natural Product As Oncogenic Kras G12c Mutant Inhibitors Via...

Findings from University of Malakand Provide New Insights into Computational Biophysics and Chemistry (Transfiguring Novel Marine Natural Product As Oncogenic Kras G12c Mutant Inhibitors Via...

2026 TTLC Symposia on RAS(ON) Inhibition in KRAS-Mutated NSCLC – IASLC

2026 TTLC Symposia on RAS(ON) Inhibition in KRAS-Mutated NSCLC – IASLC

2026 TTLC Symposia on RAS(ON) Inhibition in KRAS-Mutated NSCLC - IASLC

2026 TTLC Symposia on RAS(ON) Inhibition in KRAS-Mutated NSCLC - IASLC